相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis
Mark J. Taylor et al.
PARASITOLOGY (2014)
Overcoming the Challenges of Drug Discovery for Neglected Tropical Diseases: The A.WOL Experience
Kelly L. Johnston et al.
JOURNAL OF BIOMOLECULAR SCREENING (2014)
Phenotypic Screening as a Strategic Component of Drug Discovery Programs Targeting Novel Antiparasitic and Antimycobacterial Agents: An Editorial Miniperspectives Series on Phenotypic Screening for Antiinfective Targets
John A. Butera
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Tuberculosis success
Dan Jones
NATURE REVIEWS DRUG DISCOVERY (2013)
The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases
Thomas Spangenberg et al.
PLOS ONE (2013)
3,5-Diaryl-2-aminopyridines as a Novel Class of Orally Active Antimalarials Demonstrating Single Dose Cure in Mice and Clinical Candidate Potential
Yassir Younis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
Andreas H. Diacon et al.
LANCET (2012)
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Christopher J. L. Murray et al.
LANCET (2012)
The global pipeline of new medicines for the control and elimination of malaria
Melinda P. Anthony et al.
MALARIA JOURNAL (2012)
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
Maria Tarcela Gler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
P. falciparum In Vitro Killing Rates Allow to Discriminate between Different Antimalarial Mode-of-Action
Laura M. Sanz et al.
PLOS ONE (2012)
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar et al.
PLOS ONE (2012)
Four Lessons from Global Health Drug Discovery: Medicine for an Ailing Industry?
Richard L. Elliott
ACS MEDICINAL CHEMISTRY LETTERS (2012)
The Activities of Current Antimalarial Drugs on the Life Cycle Stages of Plasmodium: A Comparative Study with Human and Rodent Parasites
Michael Delves et al.
PLOS MEDICINE (2012)
The State of the Art in Anti-Malarial Drug Discovery and Development
Jeremy N. Burrows et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Challenges in antimalarial drug discovery
Jeremy N. Burrows et al.
FUTURE MEDICINAL CHEMISTRY (2011)
Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential
Jose M. Coteron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Spiroindolones, a Potent Compound Class for the Treatment of Malaria
Matthias Rottmann et al.
SCIENCE (2010)
Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination
Timothy N. C. Wells et al.
TRENDS IN PARASITOLOGY (2010)
Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors
Mudassar Altaf et al.
TUBERCULOSIS (2010)
Dominant Role of the sst1 Locus in Pathogenesis of Necrotizing Lung Granulomas during Chronic Tuberculosis Infection and Reactivation in Genetically Resistant Hosts
Alexander V. Pichugin et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model
K. N. Williams et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
Ramandeep Singh et al.
SCIENCE (2008)
Drugs for bad bugs: confronting the challenges of antibacterial discovery
David J. Payne et al.
NATURE REVIEWS DRUG DISCOVERY (2007)